Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Esophageal Neoplasms × Cyclophosphamide × Clear all

Phase

Phase 1 10 Phase 1/2 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 223 Lymphoma 214 Precursor Cell Lymphoblastic Leukemia-Lymphoma 173 Leukemia 159 Lymphoma, Large B-Cell, Diffuse 153 Multiple Myeloma 151 Lymphoma, Non-Hodgkin 136 Leukemia, Lymphocytic, Chronic, B-Cell 133 Leukemia, Myeloid, Acute 121 Hodgkin Disease 106 Myelodysplastic Syndromes 105 Lymphoma, Follicular 104 Burkitt Lymphoma 100 Lymphoma, Mantle-Cell 95 Lymphoma, B-Cell, Marginal Zone 70 Lymphoma, Large-Cell, Immunoblastic 61 Neoplasms, Plasma Cell 56 Recurrence 55 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 50 Myeloproliferative Disorders 46 Dendritic Cell Sarcoma, Interdigitating 45 Leukemia, Myeloid, Chronic-Phase 44 Leukemia, Myeloid, Accelerated Phase 44 Neoplasms 43 Melanoma 42 Leukemia, Myelomonocytic, Chronic 42 Waldenstrom Macroglobulinemia 37 Triple Negative Breast Neoplasms 37 Blast Crisis 36 Congenital Abnormalities 35

Interventions

Cisplatin 80 Fluorouracil 66 Paclitaxel 62 Radiotherapy 56 Oxaliplatin 51 Irinotecan 35 Docetaxel 34 Leucovorin 32 Carboplatin 30 Capecitabine 26 Radiation 25 Surgical Procedures, Operative 20 pembrolizumab 17 Drug Therapy 15 Bevacizumab 15 Cetuximab 14 Nivolumab 12 tislelizumab 11 Chemoradiotherapy 11 Albumin-Bound Paclitaxel 10 camrelizumab 9 S 1 (combination) 9 Neoadjuvant Therapy 9 Esophagectomy 9 nimotuzumab 8 durvalumab 8 Trastuzumab 8 Radiotherapy, Intensity-Modulated 7 Gefitinib 7 nedaplatin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01795976 2018-08-07

ATTACK-OG

The Christie NHS Foundation Trust

Phase 2 Terminated

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡